Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results
April 22, 2015 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., April 22, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell to Discuss First Quarter Business Performance on April 22, 2015
April 13, 2015 16:56 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., April 13, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit
March 09, 2015 17:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., March 9, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended December 31, 2014
February 25, 2015 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated, commercial stage pharmaceutical company focused on developing,...
Parnell to Report Financial Results for the Fiscal Period Ended December 31, 2014 on February 25, 2015
February 12, 2015 22:11 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference
January 12, 2015 19:40 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Management Adopts 10b5-1 Trading Plans
December 19, 2014 15:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 19, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Announces Key Senior Management and Director Appointments
December 09, 2014 17:50 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 9, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd., a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing...
Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End
December 09, 2014 17:28 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 9, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences
November 12, 2014 16:30 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...